000 | 01094 a2200301 4500 | ||
---|---|---|---|
005 | 20250515092333.0 | ||
264 | 0 | _c20080205 | |
008 | 200802s 0 0 eng d | ||
022 | _a0300-5127 | ||
024 | 7 |
_a10.1042/BST0350985 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMiddleton, D A | |
245 | 0 | 0 |
_aSolid-state NMR spectroscopy as a tool for drug design: from membrane-embedded targets to amyloid fibrils. _h[electronic resource] |
260 |
_bBiochemical Society transactions _cNov 2007 |
||
300 |
_a985-90 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAmyloid _xmetabolism |
650 | 0 | 4 | _aBinding Sites |
650 | 0 | 4 |
_aCell Membrane _xmetabolism |
650 | 0 | 4 | _aCrystallography, X-Ray |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 | _aLigands |
650 | 0 | 4 |
_aMagnetic Resonance Spectroscopy _xmethods |
650 | 0 | 4 | _aMolecular Structure |
650 | 0 | 4 | _aMutagenesis, Site-Directed |
773 | 0 |
_tBiochemical Society transactions _gvol. 35 _gno. Pt 5 _gp. 985-90 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1042/BST0350985 _zAvailable from publisher's website |
999 |
_c17475882 _d17475882 |